|Bid||0.00 x 1800|
|Ask||0.00 x 900|
|Day's Range||27.41 - 27.93|
|52 Week Range||25.06 - 37.95|
|Beta (3Y Monthly)||0.35|
|PE Ratio (TTM)||N/A|
|Earnings Date||Feb 5, 2019 - Feb 11, 2019|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||36.00|
tumbled 12.45% to $26.15 on Wednesday after the newborn medical device maker missed Wall Street's fourth-quarter earnings expectations and 2019 guidance. "Record revenue during the fourth quarter 2018 was driven by strong demand across multiple product and market segments.
Natus Medical (BABY) delivered earnings and revenue surprises of -14.00% and 3.44%, respectively, for the quarter ended December 2018. Do the numbers hold clues to what lies ahead for the stock?
Here's a roundup of top developments in the biotech space over the last 24 hours: Scaling The Peaks (Biotech stocks hitting 52-week highs on Feb. 12) Abbott Laboratories (NYSE: ABT ) Amphastar Pharmaceuticals ...
PLEASANTON, Calif. (AP) _ Natus Medical Inc. (BABY) on Wednesday reported a loss of $11.6 million in its fourth quarter. The Pleasanton, California-based company said it had a loss of 35 cents per share. For the current quarter ending in April, Natus Medical expects its per-share earnings to range from 1 cent to 8 cents.
Reports record fourth quarter revenue of $141.0 millionReports fourth quarter GAAP loss per share of $0.35 and non-GAAP earnings per share of $0.43Provides annual revenue and.
PLEASANTON, Calif., Feb. 13, 2019 -- Natus Medical Incorporated (NASDAQ: BABY) announced today a significant refreshment of its board of directors with the appointment of Alice.
Natus Medical Inc NASDAQ/NGS:BABYView full report here! Summary * ETFs holding this stock have seen outflows over the last one-month * Bearish sentiment is low and declining * Economic output for the sector is expanding but at a slower rate Bearish sentimentShort interest | PositiveShort interest is low for BABY with fewer than 5% of shares on loan. Additionally, this was an improvement in sentiment as investors who seek to profit from falling equity prices reduced their short positions on January 23. Money flowETF/Index ownership | NegativeETF activity is negative. Over the last one-month, outflows of investor capital in ETFs holding BABY totaled $921 million. Additionally, the rate of outflows appears to be accelerating. Economic sentimentPMI by IHS Markit | NegativeAccording to the latest IHS Markit Purchasing Managers' Index (PMI) data, output in the Healthcare sector is rising. The rate of growth is weak relative to the trend shown over the past year, however, and is easing. Credit worthinessCredit default swapCDS data is not available for this security.Please send all inquiries related to the report to firstname.lastname@example.org.Charts and report PDFs will only be available for 30 days after publishing.This document has been produced for information purposes only and is not to be relied upon or as construed as investment advice. To the fullest extent permitted by law, IHS Markit disclaims any responsibility or liability, whether in contract, tort (including, without limitation, negligence), equity or otherwise, for any loss or damage arising from any reliance on or the use of this material in any way. Please view the full legal disclaimer and methodology information on pages 2-3 of the full report.
Gibbs Law Group is investigating claims on behalf of investors of Natus Medical Incorporated involving possible securities law violations. Specifically, our investigation focuses on allegations that Natus Medical and certain of its officers and/or directors may have engaged in unlawful business practices or securities fraud.
Zamansky LLC announces that it is investigating Natus Medical Incorporated (BABY) (“Natus” or the “Company”) for potential breaches of fiduciary duties concerning its accounting practices, specifically with regard to its allegedly obsolete inventory. As recently reported, Natus’ accounting practices have been called into question by a third-party short seller. It has been suggested that “Natus’ warranty/bad debt reserves and prepaid expenses accounts have all been depleted/manipulated over the last year to artificially increase EPS by $0.33 (or nearly 25% of earnings).” Furthermore, the third-party short seller has alleged that Natus’ accounting practices, including its non-GAAP exclusions, raise similar concerns to another company that previously came under fire for its accounting practices: Logitech International SA (LOGI) (in 2011, Logitech was forced to restate its earnings, reduce guidance, and pay a fine in connection with a 70% drop in its share price).
NEW YORK, Feb. 07, 2019 -- Bragar Eagel & Squire, P.C. is investigating potential claims against Natus Medical Incorporated (NASDAQ: BABY). Our investigation concerns.
BOSTON, Feb. 06, 2019 -- Block & Leviton LLP (www.blockesq.com), a securities litigation firm representing investors nationwide, is investigating whether Natus Medical.
Holzer & Holzer, LLC is investigating whether certain statements made by Natus Medical, Inc. complied with federal securities laws.
Natus Medical (BABY) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Natus Medical Inc (NASDAQ: BABY ) traded lower after a short report accusing the company of deceptive accounting practices. Accounting Tricks GlassHouse alleges Natus has been using accounting tricks to ...
NEW YORK, Jan. 28, 2019 -- In new independent research reports released early this morning, Fundamental Markets released its latest key findings for all current investors,.
Natus Medical Incorporated (BABY) (the “Company” or “Natus”) today announced the implementation of a new organizational structure designed to improve operational performance and make it a stronger, more profitable company. Natus will consolidate its three business units, Neuro, Newborn Care and Otometrics into “One Natus”.
PLEASANTON, Calif., Jan. 02, 2019 -- Natus Medical Incorporated (NASDAQ: BABY) today announced that the Company will release its 2018 fourth quarter financial results before.
Investors are always looking for growth in small-cap stocks like Natus Medical Incorporated (NASDAQ:BABY), with a market cap of US$1.1b. However, an important fact which most ignore is: how financially Read More...